Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hyalex Orthopaedics, Inmode, Neuraxis, Stryker.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Canbridge, Fresenius, GSK, Novavax, SIFI, Wuxi, Zai Lab.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Hyundai, Innocare, Mesoblast, Sarepta, Sihuan.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Trax Surgical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BMS, Incyte, Pharmather, Travere, Sihuan, Xuanzhu.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amneal, Biocryst, Biohaven, Brainchild, Cabaletta, Cure Rare, Ips, Kaerus, Merck, Mesoblast, Poltreg, Xspray.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Elucent Medical, GE Healthcare, Intalight.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brightheart.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beam, Hyundai, Regenxbio, Sarepta.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apyx, Freespira, GE Healthcare, Know Bio, Prevencio, Rebrain.